Michelle A. Sy
Capiz, 5800, Philippines
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Tau isoform imbalance and aggregation are pathological hallmarks of X-linked dystonia-parkinsonism.
Journal: medRxiv : the preprint server for health sciences
Published: August 20, 2026
Therapeutic targeting of alternative splicing caused by a lethal noncoding structural variant in X-linked dystonia parkinsonism.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
Myelin pathology is a key feature of X-linked Dystonia Parkinsonism.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
MSH3 is a genetic modifier of somatic repeat instability in X-linked dystonia parkinsonism.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2025
MSH3 is a genetic modifier of somatic repeat instability in X-linked dystonia parkinsonism.
Journal: American journal of human genetics
Published: May 03, 2025
Therapeutic innovations for the symptomatic treatment of Parkinson's disease: focus on technology-based therapies.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: February 03, 2025
Targeting myeloperoxidase to reduce neuroinflammation in X-linked dystonia parkinsonism.
Journal: medRxiv : the preprint server for health sciences
Published: July 09, 2024
Targeting Myeloperoxidase to Reduce Neuroinflammation in X-Linked Dystonia Parkinsonism.
Journal: CNS neuroscience & therapeutics
Published: July 08, 2024
Showing 1-11 of 11
Last Updated: 09/26/2026